[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 507 Agreed to Senate (ATS)]
<DOC>
118th CONGRESS
1st Session
S. RES. 507
Designating September 25, 2023, as ``National Ataxia Awareness Day'',
and raising awareness of ataxia, ataxia research, and the search for a
cure.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
December 14, 2023
Mrs. Hyde-Smith (for herself, Mr. Murphy, Mrs. Capito, and Ms.
Stabenow) submitted the following resolution; which was considered and
agreed to
_______________________________________________________________________
RESOLUTION
Designating September 25, 2023, as ``National Ataxia Awareness Day'',
and raising awareness of ataxia, ataxia research, and the search for a
cure.
Whereas ataxia is a clinical manifestation indicating degeneration or
dysfunction of the brain that negatively affects the coordination,
precision, and accurate timing of physical movements;
Whereas ataxia can strike individuals of all ages, including children;
Whereas the term ``ataxia'' is used to classify a group of rare, inherited
neurodegenerative diseases including--
(1) ataxia telangiectasia;
(2) episodic ataxia;
(3) Friedreich's ataxia; and
(4) spinocerebellar ataxia;
Whereas there are many known types of genetic ataxia, but the genetic basis for
ataxia in some patients is still unknown;
Whereas all inherited ataxias affect fewer than 200,000 individuals in the
United States and, therefore, are recognized as rare diseases under the
Orphan Drug Act (Public Law 97-414; 96 Stat. 2049);
Whereas some genetic ataxias are inherited in an autosomal dominant manner while
others are inherited in an autosomal recessive manner;
Whereas ataxia symptoms can also be caused by noninherited health conditions and
other factors, including stroke, tumor, cerebral palsy, head trauma,
multiple sclerosis, alcohol addiction or misuse, and certain
medications;
Whereas ataxia can present physical, psychological, and financial challenges for
patients and their families;
Whereas symptoms and outcomes of ataxia progress at different rates and can
include--
(1) lack of coordination;
(2) slurred speech;
(3) cardiomyopathy;
(4) scoliosis;
(5) eye movement abnormalities;
(6) difficulty walking;
(7) tremors;
(8) trouble eating and swallowing;
(9) difficulties with other activities that require fine motor skills;
and
(10) death;
Whereas many patients with ataxia require the use of assistive devices, such as
wheelchairs and walkers, to aid in their mobility, and many individuals
may need physical and occupational therapy;
Whereas few treatments and no cures have been approved for ataxia; and
Whereas clinical research to develop safe and effective treatments for ataxia is
ongoing: Now, therefore, be it
Resolved, That the Senate--
(1) recognizes the need for greater public awareness of
ataxia;
(2) designates September 25, 2023, as ``National Ataxia
Awareness Day'';
(3) supports the goals of National Ataxia Awareness Day,
which are--
(A) to raise awareness of the causes and symptoms
of ataxia among the general public and health care
professionals;
(B) to improve diagnosis of ataxia and access to
care for patients affected by ataxia; and
(C) to accelerate ataxia research, including on
safe and effective treatment options and, ultimately, a
cure;
(4) recognizes the individuals in the United States who
face challenges due to having ataxia, and the families of those
individuals; and
(5) encourages States, territories, and localities to
support the goals of National Ataxia Awareness Day.
<all>